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Postmortem neuropathological studies of autism consistently reveal distinctive
types of malformations, including cortical dysplasias, heterotopias, and various
neuronomorphometric abnormalities. In keeping with these observations, we review here
that 88% of high-risk genes for autism influence neural induction and early maturation
of the neuroblast. In addition, 80% of these same genes influence later stages of
differentiation, including neurite and synapse development, suggesting that these gene
products exhibit long-lasting developmental effects on cell development as well as
elements of redundancy in processes of neural proliferation, growth, and maturation.
We also address the putative genetic overlap of autism with conditions like epilepsy and
schizophrenia, with implications to shared and divergent etiologies. This review imports
the necessity of a frameshift in our understanding of the neurodevelopmental basis of
autism to include all stages of neuronal maturation, ranging from neural induction to
synaptogenesis.
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INTRODUCTION
Neuroblasts require precise extrinsic and intrinsic signals to
acquire their unique, semi-predetermined identities. For instance,
the complement of developmental signals that produce a sero-
tonergic neuron in the raphe nucleus are different from those
that produce dopaminergic neurons in the substantia nigra, lead-
ing genetically similar neuroblasts along divergent paths (Hynes
and Rosenthal, 1999). Though signals for growth and differen-
tiation may funnel through similar pathways for all neurons,
such as the Wingless Integration Site (Wnt), Hedgehog, and
Transforming Growth Factor-β (TGF-β) families, the effectors
that regulate these pathways can vary considerably from one brain
structure to the next, allowing the creation of distinct boundaries
and the refinement of cellular identities (Wolpert and Kerszberg,
2003). From this basic arrangement arise not only variations in
morphology but function, and together these different neuronal
species commune to produce a finely-tuned, well-coordinated
network of cells.
However, in autism spectrum conditions (referred to here
collectively as “autism”), neuroimaging and electrophysiology
suggest that these networks are prone to disruption and that
disparate cognitive modules communicate comparatively asyn-
chronously (Just et al., 2007; Sokhadze et al., 2009). In sup-
port, many autistic people, for instance, have difficulties in
processing vision and speech simultaneously, two faculties
which are normally well-intertwined for most people (Murray
et al., 2005; Stevenson et al., 2014). In addition, cogni-
tive tasks that require the coordination of large networks of
cells, such as socialization, language, and executive functions,
are usually the most impaired in the conditions; meanwhile,
those tasks that necessitate smaller networks, skills sometimes
associated with savantism, are more frequently spared (Treffert,
2010).
Reflective of the large-network incoordination in autism, neu-
ropathological studies performed over the last several decades
indicate that the brains of autistic individuals are characterized
by heterogeneous dysgeneses or malformations, ranging from
subtler dysplasias affecting lateral cell dispersion within mini-
columns, to the more obvious heterotopias which can sometimes
be seen on magnetic resonance imaging (MRI) as Unidentified
Bright Objects (UBO) (Nowell et al., 1990; Casanova et al., 2002;
Wegiel et al., 2010). At the microscopic level, altered cell mor-
phologies (e.g., reduced soma size) are also often noted (Casanova
et al., 2002).
Across a series of three separate studies since 1998, various
neuropathologists have found direct evidence of neocortical dys-
genesis in autism ranging from 92 to 100% of their subjects,
indicating that disturbances to early neocortical development are
likely fundamental to the conditions (Bailey et al., 1998; Wegiel
et al., 2010; Casanova et al., 2013). Wegiel et al. also reported
that subcortical, periventricular, hippocampal, and cerebellar het-
erotopias were present in 31% of cases, meanwhile 62% of their
subjects exhibited cerebellar dysgenesis. These types of corti-
cal, subcortical, and periventricular malformations are strongly
linked with epileptic susceptibility in the general population and
probably explain the high rates of epilepsy in autism (Raymond
et al., 1995).
Considerable research energies have been devoted to the study
of autism at the level of the neurite and synapse (Auerbach et al.,
2011). It therefore becomes a challenge to rectify what appears to
be conflicting evidence arising from the fields of neuropathology
and genetics. A number of studies have suggested that neurite-
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and synapse-associated gene products, such as Contactin-
associated Protein-like 2 (Cntnap2), Neuroligin-4, X-linked
(Nlgn4x), and Neurexin-1-alpha (Nrxn1), may in fact be involved
in earlier stages of differentiation than typically acknowledged,
resulting in defects of migration and other indications of dis-
turbance to pre-migratory cell fate determination (Peñagarikano
et al., 2011; Shi et al., 2013; Zeng et al., 2013). We have there-
fore considered the possibility that some genes expressed dur-
ing early stages of neuronal development may continue to have
rippling effects on later stages of differentiation, permanently
perturbing neuronal maturation when their gene products are
impaired. Other genes may also express considerable functional
redundancy at numerous stages of cell growth and develop-
ment, likewise leading to shared disturbances in neurogenesis
and neurite extension or synaptogenesis. Thus, we have gathered
a core set of idiopathic and syndromic high-risk autism genes
in order to perform an in-depth review of their myriad cellu-
lar functions in early brain development and determine whether
commonalities exist that may explain the broad range of findings
in autism.
FUNCTIONAL OVERLAP OF CORE AUTISM GENES
We have performed an in depth review of the literature sur-
rounding a core set of 197 high-risk autism-related genes. Our
list was compiled from the SFARI and AutismKB databases.
We selected the “Syndromic,” “High Confidence,” and “Strong
Candidate” categories from the SFARI database and the core and
syndromic datasets (version 2) from the AutismKB database in
order to derive our final core set (Banerjee-Basu and Packer,
2010; Xu et al., 2012; databases accessed on 6/15/14). The lit-
erature was then reviewed in depth, focusing on regulatory
roles for each gene in neurogenesis, neural induction, and neu-
roblast differentiation. In order to better summarize our find-
ings, we applied a semi-quantitative rating system to each gene,
ranging from “0” which indicates that there is no known rela-
tion between the gene product function and neuroblast devel-
opment, to “3” in which there is a confirmed direct rela-
tionship, the latter most frequently manifest as either prema-
ture or delayed neurogenesis (see Figure 1). We also addressed
each gene’s involvement in either neuritogenesis or synapto-
genesis. If abnormal branching, synaptomorphology, or synap-
tophysiology were reported in human cases, animal models,
or in vitro studies for a specific gene, this was considered
a “hit.”
In addition to reviewing the various functions of each
gene product, we also studied their involvements in epilepsy
and schizophrenia. As discussed earlier, seizure disorder occurs
frequently in autism, and within the general epileptic pop-
ulation dyplasias, heterotopias, and ectopias are often seats
of epileptiform activity, suggesting links in the etiologies of
autism and epilepsy (Avoli et al., 1999). In order to deter-
mine a relationship between epilepsy and a given gene, the
literature was searched for indications of the gene’s involve-
ment in epileptic susceptibility; modest overlap was consid-
ered a “hit.” Likewise, gene overlap between the core set and
schizophrenia risk genes was assessed using the SzGene database
and considered a “hit” if contained therein (Allen et al.,
2008).
According to our review, 88% of core genes fell within the 2–
3 rating categories, while only 12% fell within the 0–1 rating,
suggesting that the vast majority of high-risk autism genes help
to regulate neural induction and early neuroblast differentiation
FIGURE 1 | Bar graph showing the number of high-risk autism core genes that fall within a given rating (0–3), with criteria for the rating system.
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(Figure 1; see Supplementary Table 1 for full gene list and justi-
fications for individual ratings). In addition, as was predicted at
the outset of our review, 80% of the core set genes influence pro-
cesses of neuritogenesis, synaptogenesis, and plasticity, primarily
indicated by loss-of-function in vitro and in vivo studies. Most
of these neuritic and synaptic genes (86%) likewise overlap with
the 2–3 rating category, suggesting that the majority of core genes
influence numerous stages of neuronal development and are not
limited to singular processes, many of which have probably been
exapted for a variety of related uses (Supplementary Table 1).
Meanwhile, we found that approximately 63% of the core
genes overlapped with the molecular etiology of epilepsy, span-
ning all areas of function (Figure 2; Supplementary Table 2).
Within the general autistic population, epilepsy occurs alongside
autism in approximately 26% of cases, meanwhile epileptiform
activity can be seen in about 60% of cases (Spence and Schneider,
2009; Viscidi et al., 2013). Viscidi et al. also reported, however,
that risk of epilepsy increases with severity of autistic symptomol-
ogy, and therefore considering the high genetic overlap between
autism and epilepsy presented here, this suggests that forms of
autism with strong genetic backgrounds could prove more severe
symptomologically, both in terms of autism and seizures.
In contrast, only approximately 23% of the autism core genes
overlapped with schizophrenia risk genes, neurotransmitter and
ion transport functions being overrepresented in this group, com-
prising 42% of the total overlap (Figure 2; Supplementary Table
2). Nevertheless, trophic factors, tumor suppressors, transcrip-
tional regulators, and regulators of signal transduction likewise
comprised a sizable minority accounting for 26% of the over-
lap. The remaining genes largely include products involved in
cell-cell adhesion and cytoskeletal regulation (12%), signal trans-
duction and oxidation processes within the mitochondria (4%),
and housekeeping pathways (e.g., purine and lipid synthesis)
FIGURE 2 | Bar graph showing the percentage of high-risk autism core
genes that are at least modestly cross-indicated in epileptic and
schizophrenic etiologies. Black bars indicate genetic overlap, meanwhile
gray bars indicate no evidence of overlap.
(9%). Though it is difficult to draw inferences about schizophre-
nia and autism given the paucity of genetic commonality and
the range of potential gene validity contained within the SzGene
database, the heavy preponderance of neurotransmitter-related
mutations in the overlap implies that there may be some funda-
mental differences in the two conditions’ etiologies. Of relevance
to this topic, though autism is highly comorbid with epilepsy,
only approximately 2% of epileptics in a large Danish study were
also admitted to hospital and diagnosed with either schizophre-
nia or a schizophrenia-like psychosis, indicating little in the way
of developmental overlap despite that 4/5ths of the overlapping
schizophrenia-risk genes are likewise implicated in epilepsy (Qin
et al., 2005). Interestingly, as evidenced by the early literature on
schizophrenia, scientists originally believed that epilepsy was a
protective factor against the development of schizophrenic psy-
chosis (de Meduna, 1936). However, that work was eventually
overturned and it is now believed that epilepsy occurs no more
frequently in schizophrenia than in the general population, with
the exception of schizophrenia-like psychotic features occasion-
ally associated with temporal lobe epilepsy (Qin et al., 2005).
This type of psychosis occurs in epilepsy in only approximately
4% of the epileptic population and is strongly associated with
idiopathic, rather than organic, forms of the condition (Schmitz
and Wolf, 1995). It should be noted once again that, given the
scarcity of genetic overlap, caution is warranted when interpret-
ing these observations. However, we hope that further combined
neuropathological studies on autism, epilepsy, and schizophrenia
may help delineate whether there exists a divergence in their
developmental trajectories and how that translates at the cellular
and tissue levels.
In summary, although 80% of core autism genes appear to
influence post-migratory stages of neuronal differentiation, such
as neuritogenesis and synapse development or remodeling, at
least 88% of the core set are integral in earlier stages of neural
specification, tying together evidence of gross structural neu-
ropathology in autism with reports of neuritic and synaptic
dysfunction.
CONVERGENCE DUE TO MODULARITY
MODULARITY
DNA houses templates for a vast number of gene products.
Surprisingly, though specific regulatory elements vary consid-
erably according to cell type, all cells appear to reuse similar
pathways throughout processes of cell growth, division, and dif-
ferentiation. Examples of some of these pathways mentioned
earlier include the Wnt, Hedgehog, and TGF-β families, each
of which has been well-studied during embryonic development
of numerous tissue types (Wolpert and Kerszberg, 2003). As
such, these super-pathways can be considered modules which,
through variations in their regulatory partners and upstream
effectors, lead to the differentiation of one sister cell from another
(Schlosser and Wagner, 2004). Rather than recreating the wheel
from scratch, evolution has elected to conserve these super-
pathways and instead derive new cell-specific regulators of these
and similar modules that allow the ever-expanding complexity of
different tissue types. The brain itself is an extraordinarily com-
plex array of unique cells, varying extensively in morphology
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and physiology; in order to create such tissue complexity, many
brain-specific regulators must exist to define the numerous
boundaries that occur within the adult brain, both in terms of
regional diversity and microcircuit specificity.
A module is defined as “one of a set of separate parts that can
be joined together to form a larger object.” The basic cellular
functions of the core gene set reviewed here can also be consid-
ered modular and typically funnel through the super-pathways
previously mentioned. Though their utilities vary, the functions
of these gene products overlap in several key ways, some of
which have been individually covered in the related literature
(Table 1A; Supplementary Table 3). Proper functioning of all of
these processes together orchestrates neural induction and neu-
ronal differentiation: when any one of them is disturbed, fate
determination can be altered, as shown in the succeeding exam-
ples from the core list of genes. If pervasive, this may lead to
disruption within the larger network of cells and to conditions
such as autism.
NEURAL INDUCTION AND DIFFERENTIATION ARE
ACTIVITY-DEPENDENT
Excitation is a requisite for the implementation of all stages of
neural development (Spitzer, 2006). Of particular importance
to the cortical malformations discussed here, excitation drives
progenitor expansion and neurogenesis, as well as later stages
of differentiation and plasticity (Kempermann et al., 2000; Ge
et al., 2007). This is known as activity-dependent development.
The categories of calcium regulation, neurotransmitter and neu-
romodulator regulation, cation channels and transport, and even
purine metabolism all converge to produce the necessary excita-
tory drive that induces neurogenesis and neuroblast maturation.
Table 1 | Tables summarizing the basic molecular/biological functions
of gene products targeted by mutations in the core autism set of
genes (A) and larger functional domains into which these can be
funneled, leading to disruptions in neuronal induction and
differentiation whenever their effectors are impaired (B).
(A) Basic cellular functions targeted in autism (B) Induction and
differentiation are:
• Calcium regulation
• Neurotransmitter/Neuromodulation regulation
• Vesicular transport
• Cation channel synthesis and ion transport
• Purine/Pyrimidine metabolism
• Regulation of cytoskeleton, cell adhesion, and
ciliation
• GTPase/ATPase activity
• Transcriptional/Translational regulation
• Chromatin remodeling
•Methylation and acetylation
• Neurotrophic factor activity
• Intracellular signaling transduction
• Ubiquitination
•Mitochondrial regulation/Cell detoxification
• Immune regulation
• Activity-dependent
• Structure-dependent
• Product-dependent
• Stress-sensitive
Calcium wave disruption, γ-Aminobutyric Acid (GABA) signal-
ing reduction, A-type potassium channel suppression, and distur-
bances in purine metabolism in neural progenitors each leads to
deviation in the timing and success of neurogenesis (Weissman
et al., 2004; Cancedda et al., 2007; Lin et al., 2007; Schaarschmidt
et al., 2009). These examples, reflective of some of the cellular
dysfunctions seen in autism, converge to produce neurons whose
maturations are breached either by precocious induction and dif-
ferentiation or the suppression thereof. As such, these neurons
can display a gambit of features ranging from the malforma-
tion and/or misplacement of cells which may or may not retain
neural stem cell (NSC) markers such as nestin or vimentin, to
morphologically and migratorally normal populations that may
nevertheless ectopically express characteristics atypical of their
specific identities, promoting aberrant physiologies and larger
network disturbances.
Another important example of the ectopic expression of
a progenitor-like marker relevant to autism, epilepsy, and
schizophrenia is the chloride importer, Na-K-Cl Cotransporter-
1 (NKCC1) (Palma et al., 2006). Upregulated NKCC1 mRNA
expression and increased intracellular chloride concentrations are
typical of neural progenitors, neuroblasts, and Cajal-Retzius cells,
however they are downregulated in mature pyramidal neurons,
leading to the hyperpolarizing inhibitory nature of GABAergic
signaling in the mature central nervous system (Pozas et al., 2008;
Young et al., 2012). In resected tissues of drug-resistant temporal
lobe epilepsy, for instance, mRNA levels of NKCC1 are unusu-
ally upregulated while levels of the exporter, Potassium-chloride
Transporter Member 5 (KCC2), are downregulated, suggesting
that subpopulations of neurons have either failed to mature
properly or have regressed (Huberfeld et al., 2007). This effect
ultimately leads to GABA-induced depolarization and seizures.
The drug, bumetanide, which specifically antagonizes the NKCC1
chloride importer, has not only found favor in the treatment of
some epilepsies, but has also been met with success in the treat-
ment of symptoms of autism in early drug trials and is leading
to exciting new developmental theories regarding the molecular
pathology of autism (Dzhala et al., 2005; Ben-Ari et al., 2012;
Lemonnier et al., 2012). It has also been found that downregula-
tion of KCC2 and upregulation of NKCC1 are common reactions
to neuronal stress or injury, suggesting ameans of action in symp-
tom onset in regressive forms of autism (Nabekura et al., 2002;
Kim et al., 2011).
It is clear that an exaggerated excitatory propensity in pyrami-
dal cells appears to be a risk factor for autism and epilepsy. One
of the clearest examples lies in the condition known as Timothy
Syndrome (TS), which exhibits at least 60% comorbidity rate
with autism, the highest penetrance for syndromic autism to date
(Splawski et al., 2004). The primary cause of TS is due to muta-
tions within exon 8 of the L-type voltage-gated calcium channel
gene, CACNA1C, which results in intracellular calcium overload
in affected cells, including central nervous system (OMIM, 2011).
Splawski et al. (2004) found that this exaggerated influx was
due to the loss of channel inactivation and suggested, because
of the high comorbidity rate, that calcium signaling was there-
fore strongly implicated in autism etiology. In support of this, a
form of X-linked intellectual disability (XLMR) associated with
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congenital stationary night blindness, caused by gain-of-function
mutations in another L-type voltage-gated calcium channel gene,
CACNA1F, also exhibits comorbidity with autism. Unfortunately,
this disorder is extremely rare, with most of the evidence stem-
ming from study of a single multiplex family in which three of the
five individuals affected had comorbid autism (Hemara-Wahanui
et al., 2005). However, mutations inCACNA1F have also occurred
in idiopathic autism, supporting its role as a risk gene in the
condition (AutismKB, 2012).
Defects in neuronal migration are a common feature reported
in idiopathic autism (Wegiel et al., 2010). Interestingly, both
the chloride exporter, KCC2, and calcium signaling are vital in
normal migration and may be implicated when it goes awry.
Bortone and Polleux (2009) reported that expression of KCC2
was necessary for the halt in migration of interneuronal neu-
roblasts, achieved through the reduction in membrane potential
via decreases in calcium transients. In this instance, it appears as
though the chloride exporter, through the suppression of exci-
tation, behaves as a “motogenic stop signal.” Thus, one might
fathom how changes to the level of excitatory signaling impli-
cated in autism could easily lead to the cerebral ectopias and
heterotopias seen in the condition.
Calcium and glutamate activities are also tightly linked within
the central nervous system, therefore it may come as little sur-
prise that impairment in these pathways can result in phenotypic
overlap. As example, loss-of-function mutations in the gene,
Glutamate Receptor, Ionotropic, AMPA 3 (GRIA3), lead to an
XLMR, with frequent comorbid seizure disorder and autistic fea-
tures (OMIM, 2014). Though sparse murine knockout studies fail
to implicate Gria3 in seizure susceptibility in mouse, in human its
involvement is clear given seizure comorbidity (Beyer et al., 2008).
Further study is still necessary, however, to understand the physi-
ological dysfunction resultant from GRIA3mutations that lead to
this form of seizure- and autism-susceptible XLMR.
The process of neural excitation is a modular one, composed
of numerous subunits, each of which is a potential target for dis-
ruption. As such, different genetic mutations may converge to
produce an overlapping phenotype. In this instance, calcium and
glutamate signaling each play important complementary roles
in development and when disturbed appear to influence autism
susceptibility, as well as susceptibility to seizure disorder and
intellectual disability.
NEURAL INDUCTION AND DIFFERENTIATION ARE
STRUCTURALLY-DEPENDENT
Many of the gene products not directly involved in cellular exci-
tation are instead upstream, parallel to, or downstream from it.
Downstream of excitatory signaling lie cytoskeletal and cell-cell
adhesion complexes, whose activities grant not only the capac-
ity for migration, but also orchestrate nuclear movements dur-
ing induction and the asymmetric localization of membranous
factors that stipulate that induction and further differentiation
(Fields and Itoh, 1996; Hu et al., 2008). The cellular cytoskeleton
is comprised of networks of microfilaments (e.g., actin), micro-
tubules, and intermediate filaments, each of which are highly
GTPase-dependent (Mammoto and Ingber, 2009). Actin provides
for cellular locomotion and extension. Microtubules likewise can
play roles in certain types of cilial extensions, but also provide the
overall shape for the cell, supply a network of molecular tracks
with which to shuttle vesicles to specific locations, and form the
centrosome, anchoring the cytoskeleton to the nucleus and help-
ing to direct nuclear movements vital for aspects of cell polarity.
Meanwhile, intermediate filaments provide tensile strength for
the cell (Steinert and Roop, 1988; Rodriguez et al., 2003). Each
of these cytoskeletal networks makes contacts with various adhe-
sion complexes and cell-cell junctions, relationships which are
often calcium-sensitive, if not calcium-dependent (Hirano et al.,
1987, for example). The larger relationship between coordina-
tion of the cytoskeleton and neurogenesis can be inferred in a
number of studies. Chilov et al. (2011), for instance, showed that
when the formation of the centrosome is prevented in radial glial
cells, precocious neurogenesis occurs, resulting in early deple-
tion of the progenitor pool and reduced neuron production.
Likewise, Rašin et al. (2007) reported that maintenance of the api-
cal endfoot of radial glia at the ventricular surface, maintained by
cadherins in a Numb- and Numb-like-dependent fashion, is nec-
essary for the retention of the progenitor pool, whose disturbance
can lead to either an early loss or prolonged maintenance of the
same.
But cytoskeletal dynamics play an even more fundamental role
in cell proliferation and fate switching. Chen et al. (1997) dis-
covered in a series of ground-breaking experiments that solely by
altering the basic shape of endothelial cells through varied pat-
terning of an extracellular matrix-coated substrate, cell fate could
be altered. By designing a substrate that decreased in size thereby
restricting cellular extension (i.e., “cell spreading”), cells switched
from growth to apoptosis, regardless of the type of matrix protein
used or the antibody to integrin that wasmediating adhesion. Cell
fate can also be altered by adjusting the mechanical compliance
of the substrate itself, ultimately affecting cell-generated trac-
tion forces which in turn communicate with the internal millieu
of the cell, fine-tuning pathways involved in fate determination
(Mammoto and Ingber, 2009). In summary, it appears that par-
tial suppression of cell spreading switches many epithelial cell
types from a state of proliferation to differentiation; meanwhile,
complete prevention of cell spreading often leads to apoptosis
(Mammoto and Ingber, 2009).
Consider then how impairment in a single cytoskeletal-related
protein or RNA could irreparably alter neuronal fate in autism.
In our core set of genes, there are many whose functions are
directly linked with cytoskeletal dynamics. For instance, Aarskog-
Scott Syndrome is an XLMR that is estimated to occur in 1/25,000
births, noted for its faciogenital dysplasia and mild neurobehav-
ioral features. Assumpcao et al. (1999) reported autistic sympto-
motology as an additional feature in a subset of patients, making
it a syndromic form of autism. This condition is due to a variety of
mutations within the FYVE, RhoGEF and PH Domain Containing
1 (FGD1) gene, which codes for a cell signaling protein that regu-
lates the actin cytoskeleton by activating Cell Division Cycle 42
(Cdc42), a small Rho-GTPase vital for cell dynamics (Estrada
et al., 2001).
Another cytoskeletally-related syndromic form of autism is
Opitz G/BBB Syndrome, estimated to occur in 1–9/100,000
births. This syndrome appears to be due primarily to mutations
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in theMidline 1 (MID1) gene, whose gene product has both struc-
tural and enzymatic functions. Structurally, it forms homodimers
that associate with microtubules within the cytoplasm, acting as
an anchor point for the microtubule network. Mid1 appears to
be a necessary player throughout the development of the cen-
tral nervous system: it’s expressed within neural crest cells and
is necessary for neural tube closure, it’s expressed within the pro-
liferating ventricular zone of the brain, and is even necessary for
axonal guidance (Berti et al., 2004; Thomas et al., 2008; Lu et al.,
2013).
There are many more genes in the core set, both syndromic
and non-syndromic, necessary for proper cytoskeletal function in
the developing nervous system. As we have reviewed here, one
can begin to see the complex interplay between the structural net-
work and cell fate determination. Not only does the cytoskeletal
network help to carry out changes in cell fate, it also provides
continuous feedback and can easily divert cellular development
down a different path. Thus, though their roots may diverge,
different gene mutations may ultimately overlap to produce sim-
ilar disturbances in neuronal development and neurobehavioral
symptomotology, as seen in both Aarskog-Scott and Opitz G/BBB
Syndromes.
NEURAL INDUCTION AND DIFFERENTIATION ARE
PRODUCT-DEPENDENT
Additional effectors of induction and differentiation involve the
regulation of neurotrophic factor activity, intracellular signal-
ing transduction, chromatin remodeling, gene transcription, and
protein translation. Each of these groups of molecules plays
important roles in the regulation of what is known as neural
competency or the readiness of a neural progenitor to undergo
neurogenesis and eventually to differentiate into a mature neu-
ron (Storey, 2003). Some of these factors are expressed in
cell-specific manners, while others are universal. Brain Derived
Neurotrophic Factor (BDNF) is an excellent example of a growth
factor that is widely used throughout the central nervous system
and the gene is also present within the core autism list stud-
ied here. When overexpressed, in conjunction with Epidermal
Growth Factor (EGF) availability, BDNF promotes an increase
in neurogenesis in a Phosphatidylinositol-4,5-bisphosphate 3-
kinase (PI3K)/Akt-dependent manner in vitro (Zhang et al.,
2011). Likewise, its ectopic expression in radial glia in vivo
leads to premature neurogenesis and laminar maldistribution
(Ortega and Alcántara, 2009). Overexpression of the core gene,
NTF4, which codes for Neurotrophic Factor 4, results in fur-
ther neural lineage commitment by NSCs, an effect which, like
BDNF, lies upstream of PI3K/Akt activity (Shen et al., 2010).
Akt also phosphorylates and sequesters Glycogen Synthase Kinase
3-β (GSK3β) away from β-catenin, allowing upregulation of
the canonical Wnt pathway and the normal procession of neu-
rogenesis. Similarly, the autism- and schizophrenia-associated
intracellular signaling molecule, Disrupted in Schizophrenia 1
(DISC1), inhibits GSK3β activity through its N-terminal domain,
thereby upregulating the Wnt pathway (Ming and Song, 2009).
Interestingly, loss-of-function mutations in either of the core
genes, Chromodomain Helicase DNA Binding Protein 7 (CHD7)
or CHD8, leads to derepression of Wnt; meanwhile, Phosphatase
and Tensin Homolog (PTEN) and Tuberous Sclerosis 1/2 (TSC1/2)
mutations lead directly to the upregulation of PI3K/Akt path-
way activity (Nishiyama et al., 2012; Chen et al., 2014). Together,
this evidence suggests that regulation of cell growth, well-timed
mitosis, and maturation are important factors in many forms of
autism risk.
While neurotrophic factors lie upstream of gene activation,
the epigenome regulates the shape and therefore the accessibil-
ity of target genes for transcription. In order for transcription
to occur, the euchromatin must adopt an open conformation
such that it may be competent to interact with the machin-
ery necessary for transcription initiation (Pazin and Kadonaga,
1997). Without such open conformations, target genes remain
unavailable regardless of the neurotrophic or transcription fac-
tors present. Thus, without the well-timed cooperation of the
epigenome, changes to transcription, such as those that under-
lie the shift to neurogenesis, cannot occur properly (Ballas et al.,
2005, for example). Chromatin regulators present within the core
set include not only the CHD7 and CHD8 genes as mentioned
above, but also other notable syndromic autism genes such as AT
Rich Interactive Domain 1B (ARID1B) and Methyl-CpG Binding
Domain Protein 5 (MBD5) which are associated with autosomal
dominant forms of intellectual disability, Methyl CpG Binding
Protein 2 (MECP2) whose loss-of-function mutations predispose
toward Rett’s Syndrome, Nipped-B Homolog (NIPBL) which is
associated with Cornelia de Lange Syndrome type 1, and Nuclear
Receptor Binding SET Domain Protein 1 (NSD1), the causal gene
in Sotos Syndrome (see OMIM database).
Ubiquitination of proteins is also a vital element in epige-
netic regulation. In particular, polyubiquitination of the mas-
ter regulator and repressor, Re-1 Silencing Transcription Factor
(REST), leads to the de-repression of neuronal genes and sub-
sequently to neural induction and differentiation (Stegmüller
and Bonni, 2010). In its unubiquitinated state, REST asso-
ciates with Mammalian Sin3 (mSin3) and REST Corepressor 1
(CoREST), recruiting the chromatin-associated proteins, Histone
Deacetylases (HDAC), to neural-specific genes. Thus, when ubiq-
uitination is impeded such as in a disorder of the same, REST
may continue to suppress neuronal genes, leading to delayed
induction (Stegmüller and Bonni, 2010). A perfect example of
this lies in Angelman Syndrome (AS). AS is a form of intellec-
tual disability that often presents with autistic symptomology.
Maternally-inherited mutations in the Ubiquitin Protein Ligase
E3A (UBE3A) gene, whose gene product is an integral part of the
ubiquitin-induced protein degradation system, are the primary
cause of this condition: in 25% of cases, mutation to the UBE3A
gene itself are causal, meanwhile the vast majority of patients
display larger chromosomal deletions that encompass UBE3A in
addition to other genes (OMIM, 2012). While research is unfor-
tunately sparse on the topic of neurogenesis in AS, one study by
Mardirossian et al. (2009) did show that, while neuronal pro-
liferation in the hippocampus did not appear to be affected in
mouse models of the same, expression of mature neuronal mark-
ers (e.g., NeuN) was markedly reduced, indicating perturbations
to successful maturation. Other research suggests that UBE3A
plays an important role at the centrosome, with its levels peaking
at the stage of mitosis, and is vital in chromosomal segration and
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nuclear kinesis (Singhmar and Kumar, 2011). As will be discussed
later, models of AS also exhibit disturbances to neurite extension
and plasticity.
The overall regulation of transcription and translation is a
prime means to maintain homeostasis within a cell. Therefore,
in order to induce change, target transcription and translation
must occur (Storey, 2003). For transcription, not only must
target genes be made conformationally available through epige-
nomic changes as discussed, the transcription factors themselves
must be produced and readily available within the nucleus in
order to bind to their targets. Thus, gene mutations that tar-
get transcription or function of these factors can lead to similar
dysfunctions as noted in disorders of acetylation or methyla-
tion, ultimately leading to impaired transcription of target genes
(Miller et al., 1999; Nishiyama et al., 2012). However, aside from
transcription, it has more recently been acknowledged that the
regulation of translation is vital for maintaining cell homeosta-
sis. Eukaryotic Initiation Factors (eIF), for instance, are highly
conserved positive and negative regulators of translation, and
their behaviors are often dependent upon specific binding part-
ners. While eIF4AII is a key inducer of neural competence in
the embryonic neuroectoderm in Xenopus via the upregulation
of translation, eIF4E in humans binds with both Fmr1 and
Cyfip1 to form a complex that instead inhibits protein transla-
tion (Storey, 2003; Napoli et al., 2008). These regulators behave
in a graded fashion such that when a complex suppresses transla-
tion, the cell requires greater numbers of neural inducing factors
in order to overcome that suppression and acquire a neuronal fate
(Storey, 2003). Therefore, in a condition such as FXS, in which
Fragile X Mental Retardation (FMR1), EIF4E, or Cytoplasmic
FMR1-interacting Protein 1 (CYFIP1) are mutated, the complex’s
capacity for translation suppression is reduced and precocious
induction and differentiation occur due to the lower thresh-
old requirement that gradients of neural inducing factors must
achieve (Storey, 2003; Castrén et al., 2005). As such precocious
induction leads to disturbedmaturation in FXS and increased risk
for autism.
NEURAL INDUCTION AND DIFFERENTIATION ARE STRESS-SENSITIVE
A novel concept, termed hormesis, has emerged over the last
few decades that deals with the refractory or compensatory
nature of cellular growth following stress or insult (Naviaux,
2014). Such stresses tend to produce mismatch between resource
availability and metabolic requirements, and are rapidly fol-
lowed by increased purinergic signaling and the production of
reactive oxygen species (ROS) and Krebs cycle intermediates.
The cell responds with the activation of anti-inflammatory and
regenerative pathways, the latter which appears to include the
downregulation of the KCC2 chloride exporter in neurons and the
reacquisition of GABA once again as an excitatory neurotransmit-
ter (Kim et al., 2011; Naviaux, 2014).
Several syndromic forms of autism are rooted in oxidative
and mitochondrial dysfunction. Pyridoxine-dependent epilepsy
(EPD), for instance, is due to mutations in the Aldehyde
Dehydrogenase 7 Family, Member A1 (ALDH7A1) gene whose
gene product metabolizes methyl donors and various aldehydes
thereby protecting against oxidative stress (GeneCards, 2014a).
EPD is characterized by a variety of seizure types, all typically
resistant to anticonvulsant therapy but responsive to pyridox-
ine, a form of vitamin B6. The vast majority of those with EPD
also exhibit developmental delay, including psychomotor and lan-
guage retardation. A minority of children also develop autism
which, like the epilepsy, often responds to pyridoxine treatment
in effected individuals (Mills et al., 2010). Interestingly, as a
group those with idiopathic autism have increased rates of mito-
chondrial mutations, an indicator of mitochondrial stress and
ROS-mediated damage (Napoli et al., 2013).
To understand what such metabolic and ROS-mediated dys-
function may be doing to the developing brain, one need only
look to the bourgeoning literature on the subject. For instance,
mitochondrial disturbances have clear effects on adult neuro-
genesis within the hippocampus, suppressing proliferation and
reducing total neuroblast numbers (Calingasan et al., 2008).
Similarly, inflammation, driven by microglia, astrocytes, and
macrophages, can have a range of consequences on cell growth,
proliferation, and repair depending upon the precise cocktail of
pro-inflammatory and anti-inflammatory factors released into
the local environment. A recent article by Le Belle et al. (2014)
illustrates this well: the authors exposed wildtype mouse pups
on embryonic day 9 to lipopolysaccharide (LPS), a molecule nor-
mally present on the surfaces of gram-negative bacteria that elicits
a strong immune response in animals. Not only did the pups dis-
play postnatal megalencephaly as compared to vehicle-exposed
pups, cortical thickness was increased and greater numbers of
neocortical Nestin+ progenitors incorporated bromodeoxyuri-
dine, indicating increased rates of proliferation. The authors went
on to perform the identical experiment on a mouse model for
autism, the Pten heterozygous knockout. Results were similar in
trend to the wildtype-exposed mice, however the Pten response
was exponentially exaggerated as compared to wildtype-exposed
mice and Pten mice exposed to vehicle alone. Not only does this
indicate the potential importance of prenatal infection in the
development of a phenotype linked with autism (i.e., cerebral
hyperplasia), it also shows how genetic susceptibility (e.g., Pten
knockout), together with environmental exposure can supply an
exponential, not just additive, effect on outcome.
In general, acute inflammation tends to have a stimulatory
effect on neurogenesis, meanwhile, chronic inflammation sup-
presses it (Whitney et al., 2009). One therefore might wonder
whether prenatal disturbances to the different arms of the cellular
stress pathways could lead to overlapping phenotypes, resulting
in autism in a subset of patients. Hopefully future research will
address this question. This area of research, in particular, also
holds considerable hope for treatment intervention and preven-
tion given that the nature of the causal influences may be partly
environmental.
HOW PERTURBATIONS IN NEURONAL MATURATION MAY AFFECT
NEURAL NETWORKS IN AUTISM
Studies utilizing MRI have reported a range of findings in autism,
from largescale underconnectivity to local overconnectivity, as
well as other mixed results (Maximo et al., 2014). In vitro and
animal models of autism, both syndromic and non-syndromic
alike, also display an array of findings dependent upon the model
Frontiers in Cellular Neuroscience www.frontiersin.org November 2014 | Volume 8 | Article 397 | 7
Casanova and Casanova Neuronal maturation in autism
studied, including various alterations to neuritic length, branch-
ing complexity, and synaptic density (Ramocki and Zoghbi,
2008). While we can’t address in this paper how disturbances
to early neuronal maturation might lead to such a broad range
of connectivity patterns and ultimately how those patterns over-
lap to produce the neurobehavioral phenotype known as autism,
we can however provide evidence that illustrates how neuronal
induction and differentiation are tightly linked processes.
As reviewed earlier, higher ratios of the chloride importer,
NKCC1, to that of the exporter, KCC2, are features common to
neural progenitors and neuroblasts. In addition, higher levels of
NKCC1 postnatally may also be an indicator of pathology in both
autism and epilepsy, leading to GABA-induced depolarization
and poorly-restrained pyramidal cell excitation. Knockdown of
NKCC1 in neural progenitors in the subventricular zone of mice
results in reduced GABAA-induced depolarization and significant
decreases in the number of proliferative Ki67+ progenitors and
neuronal density, indicating the importance of excitatory activ-
ity in the progenitor population and their progeny (Young et al.,
2012). Knockdown in the same cells also produces neurons with
truncated dendritic arbors at the time of synaptic integration.
Though by 6 weeks Young et al. report partial recovery in den-
dritic complexity, dendritic length was permanently altered. This
suggests that neuritic elongation is a separate though overlapping
process from that of branching and is comparably less plastic,
which previous research has shown to be the case (Goldberg,
2004). This study also suggests that early cell fate determination
may have a cascading effect on later stages of neuronal devel-
opment. This is also complicated by the fact that many gene
products are reused throughout various stages; therefore, when
a single gene is mutated targeting some or all of its transcript
variants, the effects may reverberate throughout the life of the
neuron.
Another good example to illustrate how induction and early
differentiation are linked is a form of XLMR caused by loss-of-
function mutations in the Ubiquitin Specific Peptidase 9, X-linked
(USP9X) gene. Though the condition appears quite rare, Homan
et al. (2014) reported that 1/3rd of the individuals studied dis-
played distinctive autistic features, potentially making it a sig-
nificant form of syndromic autism. The gene product itself is a
deubiquitinase involved in protein degradation and turnover, as
well as regulating pathway activities dependent upon monoubiq-
uitination signals (GeneCards, 2014b). As such, it affects a wide
array of cellular processes at all stages of development. Jolly et al.
(2009), for instance, found that when Usp9x was overexpressed
in neural progenitors in mouse, self-renewal was enhanced lead-
ing to a fivefold increase in progenitor and neuronal numbers.
In contrast, Homan et al. studied Usp9x murine knockout and
though they failed to address disturbances in neurogenesis, they
did however find that knockout resulted in a significant reduction
in axonal growth and severe neuronal migrational disturbances.
Once again, this highlights the linkage between neurogenesis and
neuritogenesis and how impairment in one, such as occurs in
autism, often coincides with impairment in the other.
Dual-specificity Tyrosine-(Y)-phosphorylation Regulated
Kinase 1A (Dyrk1A) is a protein kinase that targets serine and
threonine residues for phosophorylation, and though its exact
functions are not yet well understood, its substrates include
a variety of transcription factors, splicing factors, and even
eukaryotic initiation factors (Park et al., 2009). Most importantly,
its overexpression is the most frequent cause of Down’s Syndrome
and comorbid syndromic autism and, like Ups9x, is involved in
numerous stages of neuronal development. Yabut et al. (2010)
report that the protein’s overexpression leads to inhibition of
neural progenitor proliferation and induces premature neu-
rogenesis. Studies in Drosophila melanogaster likewise concur
that it is an essential effector in postembryonic neurogenesis in
the fruitfly (Park et al., 2009). And, in keeping with the topic
of this review, Dyrk1A overexpression leads to disturbances
in neuronal morphogenesis: while fetuses and newborns with
Down’s display apparently normal or even increased dendritic
branching, by adulthood that branching complexity is severely
reduced (Martinez de Lagran et al., 2012).
Like Down’s Syndrome, those with idiopathic autism show a
reduction in the overall size of the corpus callosum, the tract
of white matter connecting the two cerebral hemispheres (Teipel
et al., 2003; Casanova et al., 2011). This finding is also tightly pos-
itively correlated with gyral window size, the aperture through
which all cortical efferent and afferent fibers pass (Casanova et al.,
2009). These findings agree well with the largescale underconnec-
tivity reported in autism. Specifically,MRI reports of disturbances
to connectivity in the condition indicate abnormalities in the
axonal compartment of neurons, as current imaging techniques
are incapable of acquiring information on the unmyelinated den-
dritic comparment. At the cellular level one would therefore
expect to see correlates reflective of these disturbances and a
number of studies suggest that this is indeed the case (Choi
et al., 2008; Tessier and Broadie, 2008; de Anda et al., 2012, for
examples). Surprisingly, however, the dendritic compartment has
received much more research attention in spite of the MRI stud-
ies. Results of molecular and cellular research suggest that all
neuritic compartments, both axonal and dendritic, are affected
across the broad spectrum of autism, though specific phenotypes
may vary according to causation (Ramocki and Zoghbi, 2008, for
examples).
The above examples cover a wide breadth of disturbances,
from chloride importer/exporters to deubiquitinases to intra-
cellular signaling molecules, yet they nevertheless converge to
produce neurogenic and neuritogenic disturbances across the dif-
ferent forms of autism. This can be seen both at the cellular and
macroscopic levels and includes: megalencephaly/microcephaly,
signs of disturbed neurogenesis, altered cortical thickness, gyral
distortions, dysplastic formations, ectopias and heterotopias,
changes to white matter volume and functional connectivity, and
altered neurite elongation and branching complexity (Fombonne
et al., 1999; Hardan et al., 2006; Just et al., 2007; Williams
et al., 2012). Ultimately, this broad range of disturbances leads
to autistic symptomology in a significant subset of individuals.
Yet why penetrance for genes with even the strongest of associa-
tions fails to produce autism in all cases is still a partial mystery,
and undoubtedly reflects the complex etiology of the condi-
tion. However, though there are still many mysteries to solve in
autism, hopefully we have illustrated how neural induction and
differentiation are closely linked processes that are both highly
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activity-dependent, structurally-dependent on the dynamism of
the underlying cytoskeleton and adhesive complexes, and heav-
ily product-dependent in terms of transcription initiation and
translation of those factors that promote maturation (Table 1B).
In addition, they are also stress-sensitive, as can be seen with
some mitochondrial and immune disorders or prenatal infec-
tions. Ultimately, each of these larger modules converge to pro-
duce a healthy, mature neuron—or, in the case of autism, neurons
whose maturations have been hindered or redirected to an atyp-
ical phenotype, potentially preventing their proper integration
into a larger coherent network of cells.
DISCUSSION
“The overlap of neurodevelopmental and psychiatric phenotypes
(such as mental retardation, epilepsy, autism, and other abnormal
behaviours) that results from either loss or gain of the same proteins
or RNA molecules supports an emerging theme that normal cogni-
tion and behaviour depend on tight neuronal homeostatic control
mechanisms” (Ramocki and Zoghbi, 2008, p. 916).
The above quote touches on the unusual fact that even though
conditions such as FXS, AS, and Rett’s Syndrome (RTT) overlap
neurobehaviorally, their morphological and physiological phe-
notypes can be distinctly divergent. For instance, while FXS
neurons exhibit normal dendrites and increased density of den-
dritic spines, AS neurons have normal dendrites and decreased
density of dendritic spines; meanwhile, RTT neurons display a
reduction in both dendrites and spines (Ramocki and Zoghbi,
2008). Yet, curiously, each of these conditions is often comor-
bid with autism. And as Ramocki and Zoghbi suggest, what these
phenotypes may share in common is the impairment in neu-
ral network integration. Other authors of late have touched on
similar themes: Auerbach et al. (2011), for instance, reported
that mouse models of FXS and Tuberous Sclerosis (TSC) exhibit
synaptic dysfunction that falls at opposite ends of a physiolog-
ical spectrum, displaying divergent trends in longterm synaptic
depression (LTD)-related protein synthesis in hippocampus. The
authors conclude that their “findings reveal that even genetically
heterogeneous causes of [autism] and intellectual disability may
produce similar deficits by bidirectional deviations from normal
on a common functional axis” (p. 67).
While the present authors would hesitate to use the term home-
ostasis as proposed by Ramocki and Zoghbi (2008) to describe
the above events, there does appear to be a common thresh-
old of vulnerability that is surpassed in each of these syndromic
cases. What that physiological and/or morphological threshold
may be is unknown, although disturbances in cell identity, migra-
tion, neuritic, and synaptic morphology and physiology all indi-
cate that the ways in which these cells communicate with one
another is probably markedly impaired. How that impairment
leads specifically to autism symptomology requires further study
however.
Yet we would extend Ramocki and Zoghbi’s (2008) frame-
work beyond the neurite and synapse to all stages of neuronal
development and ground this work in neuropathological data
common to both the idiopathic and syndromic forms. Though
it is likely true that behavioral symptoms are ultimately mani-
fest from disturbances in network communication, as it is the
relationship amongst cells that defines brain function, the root
of dysfunction is not necessarily relegated to the communica-
tive arbors alone but appears to reach back well into the early
development of the newborn neuron and is susceptible to dis-
turbances at numerous points within a vast molecular network.
The capacity for maturational regression of neuronal populations
also suggests that all neurons, under select circumstances, have the
propensity to develop a similar phenotype to those whose devel-
opments were perturbed earlier in prenatal development, though
further work on regression is required in order to better under-
stand these underlying pathological processes. But, ultimately,
within an organ that contains incredible regional diversity, innu-
merable structural and molecular boundaries, and considerable
circuit specificity, small effects to fundamental regulators of cel-
lular identity can lead to pervasive malformation and extensive
physiological dysfunction.
In this review, we have summarized evidence indicating that
the core set of idiopathic and syndromic autism risk genes func-
tionally overlaps at stages of neural induction and early matura-
tion of the neuron. The majority of these same gene products,
however, continue to serve roles in later stages of neuronal dif-
ferentiation, linking common findings in the cytoarchitectural
neuropathology of the conditions with molecular and functional
studies that indicate disturbances to connectivity and synapse
function. Because each developmental stage lies foundational to
the next, modules, such as calcium signaling, cytoskeletal remod-
eling, and translation regulation, can target numerous down-
stream stages of growth and differentiation. As such, when distur-
bances are observed in one aspect of neuronal development, such
as branching complexity, it may be reflective of a deeper funda-
mental disturbance to neuronal maturation. Thus, the researcher
may need to look to earlier stages of the neuron’s history to better
understand the origin of the observed phenotype.
This review also highlights the genetic relationship, as well
as the neuropathological one, between autism and epilepsy. We
find that 63% of the core set shares at least modest overlap
with known risk genes for epilepsy. In addition, not only do
approximately 26% of cases of autism display comorbid seizure
disorder, the two conditions share similar dysgenic underpinnings
in the form of dysplasias, heterotopias, and ectopias. Finally, they
both express molecular indicators of neuronal immaturity by way
of progenitor-like ratios of chloride importer/exporters. Taken
together, this evidence suggests that autism and epilepsy share
very similar origins.
The genetics of schizophrenia show comparatively less over-
lap with the autism core set; however, the percentage is still
considerable at 23%. Interestingly, although the majority of over-
lapping genes are likewise indicated in seizure etiology, there
appears to be little in the way of diagnostic comorbidity between
schizophrenia and epilepsy. However, in spite of the dearth of
evidence, schizophrenic brains nevertheless exhibit similar mark-
ers of neuronal immaturity (e.g., NKCC1) within neocortex and
hippocampus as seen in autism and epilepsy (Hyde et al., 2011).
Walton et al. (2012) reported additional features of immaturity
within the dentate gyrus in schizophrenia, including increased
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numbers of calretinin-positive progenitors, decreased calbindin-
positive neurons, and increased neurogenesis, all indicators of
the perturbation of neuronal maturation. At the cytoarchitectural
level, decreased cortical thickness has been reported in the more
severe childhood- and adolescent-onset forms of schizophrenia, a
finding that is reminiscent of the dysplastic cortical thinning seen
in autism and epilepsy as well (White et al., 2003;McDonald et al.,
2008; Casanova et al., 2013). Therefore, although schizophrenia
and epilepsy are rarely comorbid, they do appear to share simi-
larities at the developmental level. Further research may help us
understand both the convergent and divergent features of autism,
epilepsy, and schizophrenia, providing better criteria by which
to differentiate their origins as well as to understand shared risk
factors.
We believe this is the first publication to view the broad spec-
trum of autism genetics through the lens of neuropathological
data. As such, we hope that it provides a framework in which
an extensive range of research interests may finally find common
ground. The culmination of research to date suggests that, though
later stages of differentiation are indeed disturbed in autism,
encompassing neurite and synapse formation and function, the
genesis of these features is generally rooted in even earlier stages of
neuronal development and are the result of deviations in cellular
identity. Therefore, investigative efforts focusing more holistically
on all stages of neuronal development in autism, from progen-
itor expansion to plasticity, may prove more fruitful than the
developmental and morphological compartmentalization that is
currently en vogue.
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